Abstrait

Future of Nanotechnology in curing infectious diseases

Kanishq Chandraprakash

Globally, infectious diseases are a major cause of morbidity and mortality. Malaria, TB, and human immunodeficiency virus infection are particularly difficult to treat, as seen by their continued transmission and high fatality rates. Low on-target bioavailability, sub-therapeutic drug accumulation in microbial sanctuaries and reservoirs, and low patient adherence due to drug-related toxicities and longer therapeutic regimens are among the problems involved with the treatment of these disorders. Nanocarriers can also be utilised to make vaccinations, which are a powerful tool in the fight against infectious diseases. In this article, we look at the present burden of infectious illnesses, focusing on the leading causes of morbidity and mortality. We then discuss how nanotechnology could help to improve current therapy options. We summarize our progress so far and outline potential future directions to maximize the impact of nanotechnology on the global population.